Minimally modified low density lipoprotein stimulates monocyte endothelial interactions

J A Berliner1, M C Territo, A Sevanian

  • 1Department of Pathology, University of California, School of Medicine, Los Angeles 90024-1732.

Insights

Minimally modified LDL (MM-LDL) significantly boosts monocyte-endothelial cell interactions and enhances resistance to MM-LDL toxicity. This study reveals MM-LDL

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Cell Biology

Background:

  • Endothelial cells (EC) play a crucial role in regulating immune cell interactions.
  • Modified forms of low-density lipoprotein (LDL) can influence EC function and inflammatory responses.

Purpose of the Study:

  • To investigate the impact of minimally modified LDL (MM-LDL) on endothelial cell interactions with monocytes and neutrophils.
  • To explore the mechanisms underlying MM-LDL-induced changes in endothelial cell behavior and toxicity.

Main Methods:

  • Treatment of large vessel endothelial cells (EC) with MM-LDL preparations.
  • Quantification of monocyte and neutrophil binding to EC.
  • Assessment of chemotactic factor production by EC.
  • Evaluation of MM-LDL toxicity and induced resistance in EC.

Main Results:

  • MM-LDL significantly increased monocyte chemotactic factor production and monocyte binding to EC.
  • Monocyte binding peaked at 4 hours and persisted for 48 hours.
  • Neutrophil binding to EC was not significantly affected by MM-LDL.
  • MM-LDL exhibited differential toxicity to EC, with some strains becoming resistant after pre-incubation.

Conclusions:

  • Sublethal exposure to MM-LDL enhances monocyte-endothelial cell interactions.
  • EC can develop resistance to the toxic effects of MM-LDL.
  • These findings highlight a novel mechanism of immune cell modulation by modified lipoproteins.